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A review ofthestudiesdone at Yaleon the roleofMSH in regulating pigmentation and growth
of Cloudman (S91) melanoma cells is presented. The areas covered include the isolation and
analyses of mutant cell lines unresponsive to MSH; the role of cyclic AMP, cyclic AMP-
dependent protein kinases, and protein phosphorylation reactions in the response of MSH; new
regulators ofthe melanogenesis pathway; thecytotoxicityofmelanin precursors; thedevelopment
of methodology for synthesizing '25I-,6-MSH; the use of this ligand to study receptors for MSH;
and the chemical and biological properties of phosphorylated isomers of L-dopa, a new class of
compounds exhibiting potent bio-activity toward melanocytes. All of the experiments described
were carried out in the Department of Dermatology at the Yale University School of Medicine
during the tenure of Dr. Aaron B. Lerner as chairman.
INTRODUCTION
In the early part of this century it was discovered that experimental removal of
pituitary glands from tadpoles resulted in rapid lightening of their integument, and
that addition of pituitary extracts to the water in which these animals were living
reversed the effect, causing integumental darkening [1,2]. Subsequent studies revealed
that theactive ingredients ofthe pituitary extracts belonged to a class ofclosely related
peptides today known interchangeably as melanotropins, melanocyte stimulating
hormones, orsimply MSH. Melanotropins aresynthesized as partofa larger precursor
molecule, pro-opiomelanocortin [3]. Three forms have been described, a, A, and y,
ranging in size from 12 to 18 amino acids. Each of the three peptides has sequence
homology to adrenocorticotropic hormone (ACTH) and to f-lipotropin (f3-LPH).
MSH, as these peptides will henceforth be referred to, is active throughout the
vertebrate kingdom in stimulating the pigmentary system [4,5], although the mecha-
nisms of action differ between the lower vertebrates and mammals. In addition to
stimulation ofthe pigmentary system, there are a numberofother functions that might
be assigned to MSH; for example, in regulation of synaptic transmission [6] and in
aldosterone biosynthesis in adrenal glomerulosa cells [7]. Whether or not a cell is able
to respond to MSH is likely to depend on the ability to express high affinity receptors
for MSH and to exhibit biochemical pathways that are regulated by the formation of
the MSH-receptor complexes [8]. In 1973, Wong and Pawelek first demonstrated that
Cloudman S91 mouse melanoma cells growing in culture respond to MSH with
increases in pigmentation, as well as alterations in morphology and rates ofprolifera-
tion [9]. Since that initial observation, there have been a number ofstudies with these
cells on various aspects of the mechanisms of action of MSH. Evidence has been
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obtained to support the following conclusions: (a) MSH binds to specific, high-affinity
receptors on the cell surface [10,11]; (b) formation ofthe hormone-receptor complex is
followed by a stimulation of the adenylate cyclase system and a net increase in
intracellular levels ofcyclic AMP (cAMP) [12,13]; (c) the hormone-receptor complex
is internalized and apparently migrates to premelanosomes, the intracellular sites of
melanin synthesis [8]; (d) the increased levels of cAMP result in increased tyrosinase
(EC 1.14.18.8) activity and melanin deposition as well as changes in morphology and
rates of proliferation [9]; and (e) these processes are mediated, at least in part, by
cAMP-dependent protein kinases [14-16].
The purpose of this article is to review the evidence in support of the above
conclusions focusing on the research done at Yale, as well as to present some recent,
and as yet unpublished, findings which extend these ongoing studies.
ISOLATION OF GENETIC VARIANTS OF THE CLOUDMAN
MELANOMA LINE
In 1973, it was first shown that MSH can reduce the growth rate of Cloudman
melanoma cells in culture [9]. This observation opened the way for isolating mutant
cell lines which were resistant to these suppressive effects of MSH on proliferation.
Subsequent studies resulted in the establishment oftechniques for isolating pure lines
of cells that did not respond to MSH and showed no changes in either pigment
formation, morphology, or rates of proliferation [17,18]. Analyses of the defects in
these mutants allowed us to conclude that there are common biochemical pathways for
the control of different cellular functions by MSH. For example, cells selected for
resistance to MSH in growth frequently also showed no increase in pigmentation in
response to MSH, even though no selective pressure had been applied for pigmenta-
tion. Since the appearance of a particular mutant trait is a rare event (one in 106) the
chances of having a second trait occur as an independent mutation and be isolated
accidentally with no selective pressure would be extremely rare, statistically 10-6 x
10-6, or one in 1012. It is therefore virtually impossible to isolate double mutants
without selective pressure. The more likely conclusion is that a single mutational event
affected both proliferation and pigmentation, and reciprocally in "normal" melanoma
cells a common biochemical step controls both functions. One common biochemical
pathway controlling responses to MSH is the cyclic cAMP system.
THE ROLE OF CYCLIC AMP IN THE RESPONSES TO MSH
The responses to MSH are apparently mediated through increases in intracellular
levels of cAMP. MSH causes a rapid and dramatic increase in ccAMP levels. The
action of MSH is mimicked by analogues of cAMP such as dibutyryl cAMP or
8-bromo cAMP, as well as agents that raise intracellular levels of cAMP, such as
cholera toxin, prostaglandin E,, theophylline, or isobutylmethylxanthine. Some
mutant cell lines that do not respond to MSH with changes in growth or pigmentation
also do not show increases in intracellular levels of cAMP [18].
CYCLIC AMP-DEPENDENT PROTEIN KINASE
Kuo and Greengard's observations on the widespread occurrence of cAMP-
dependent protein kinases throughout the phyla suggested that these enzymes are the
mediators ofthe many and varied responses to cAMP [19]. This situation appears to be
true, at least in part, for MSH and Cloudman melanoma cells. Two lines of evidence
572MSH ACTION ON CLOUDMAN MELANOMA
are as follows. First, it was shown that theactivity oftyrosinase, a rate-limiting enzyme
in melanin biosynthesis, is increased in intact cells by MSH or by analogues ofcAMP
[9,18]. In 1977, it was reported that this increased tyrosinase activity could be
achieved in a test tube using extracts of melanoma cells, cyclic cAMP, ATP,
magnesium, and a partially purified cAMP-dependent protein kinase prepared from
the same cells [14]. Second, it was shown that a cAMP-dependent protein kinase from
Cloudman cells is involved in the regulation of proliferation by MSH [15]. The
involvement ofcAMP-dependent protein kinases in these functions implies that protein
phosphorylation/dephosphorylation reactions are part of the biochemical pathway
influenced by MSH [16].
ROLE OF PHOSPHOPROTEINS
A number of observations led us to conclude that phosphoproteins are important in
the regulation of proliferation and pigmentation. Indirect evidence, discussed above,
comes from the findings that the action of MSH is mediated through cAMP-
dependent protein kinase activity. Through direct analyses, we have observed as many
as eight proteins whose phosphorylation is regulated by MSH [16]. This phenomenon
is highly complex in that there are several subsets of regulatory steps involved. Some
proteins show decreased phosphorylation in lysates of cells exposed to MSH; others
show increased phosphorylation. One group of proteins of approximately 47,000
daltons shows increased phosphorylation when cAMP is included in the reaction mix,
but only in cells not exposed to MSH. None of the other MSH-regulated proteins is
affected by cAMP in the in vitro reaction mix. Phosphorylation of three proteins is
regulated "qualitatively" by MSH in that exposure to the hormone seems to result in a
switch between phosphorylation oftyrosine residues and phosphorylation ofserine and
threonine residues. This finding could be extremely important, because phosphoryla-
tion of tyrosine residues has recently been linked to the control of growth. The
possibility is raised that the "phosphotyrosine proteins" are those involved in growth
regulation, while the others are involved in regulation ofmelanogenesis.
NEW REGULATORS OF THE MELANOGENESIS PATHWAY
Melanin is formed spontaneously from dopaquinone in a test tube. This fact led to a
generally accepted conclusion that the only catalyzed steps in melanogenesis are the
conversion of tyrosine to dopa and of dopa to dopaquinone by tyrosinase. However,
recent studies, beginning with those ofLogan and Weatherhead on Siberian hamsters,
have indicated that there are additional regulatory points governing the Mason-Raper
pathway [20-26]. Using amelanotic Cloudman cells which lacked tyrosinase activity,
we showed that dopachrome conversion factor accelerates the conversion of dopa-
chrome into 5, 6-dihydroxyindole-2-carboxylic acid, and that indole blocking factor
inhibits the conversion of5,6-dihydroxyindole (5,6-DHI) into melanochrome [21-23].
Also, we showed that melanotic cells possess an activity that accelerates the conversion
of 5,6-DHI into melanochrome and that this activity can at least in part be accounted
for by tyrosinase itself [24]. Therefore, this unusual enzyme can catalyze three
reactions in the synthesis of melanin [24]. In addition we have observed in Cloudman
cells and in skins from neonatal mice an activity, distinct from that oftyrosinase, which
also accelerates conversion of 5,6-DHI into melanochrome [25]. The nature of this
activity is as yet unknown.
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Barber and King have confirmed and extended our observations of dopachrome
conversion factor and indoleblocking factor activities [26]. They have measured these
activities in a variety of different sources, including human hair bulbs. Their studies
have led them to conclude that the activities can be accounted for by a single enzyme.
We have as yet been unable to separate dopachrome conversion factor and indole
blocking factor activities from each other, consistent with the "single enzyme"
proposal ofBarber and King. However, it should be pointed out that until the activities
arepurified tohomogeneity, no definitive statement regarding this situation is possible
[27].
Taken together, the results from three separate laboratories support the notion that
there are regulatory steps in the Mason-Raper pathway following the formation of
dopaquinone. To our knowledge, these regulated steps have been observed exclusively
in eumelanogenic systems, and it remains to be seen whether they also are involved in
pheomelanogenesis. It is our feeling that many additional regulatory events in these
pathways exist. In this regard, we found that in some, but not all experiments, melanin
formed by extracts of skins from brown mice was brown, whereas melanin formed by
extracts of skins from sombre mice and from black mice was always black [25]. This
was surprising since differences in color between brown and black mice were
considered to be due to size and shapes of melanosomes rather than color of the
melanin [28]. Since we observed differences in color between the melanins synthesized
in the absence ofmelanosomes, perhaps there are determinants in skin extracts which
regulate formation of brown or black melanin.
CYTOTOXICITY OF MELANIN PRECURSORS
From a variety of clinical and experimental observations, Lerner proposed several
years ago that, during the process ofmelanization, a pigment cell produces substances
which are potentially autotoxic [29]. Since that proposal, several laboratories have
confirmed that the precursors of melanin biosynthesis are highly toxic to melanoma
cells, probably because of their ability to generate free radicals as they co-polymerize.
We showed that tyrosine and dopa are toxic to melanoma cells in culture and that the
toxicity is increased significantly ifthe cells are pre-exposed to MSH [13,23]. We also
showed that other intermediates, namely dopachrome and 5,6-DHI, are even more
toxic than tyrosine and dopa [23,30]. However, cells that synthesize melanin possess
mechanisms for protecting themselves from the cytotoxic intermediates, and our
evidence indicates that, in Cloudman melanoma cells, the protective mechanism is
related tothe relative activities oftyrosinase,dopachrome conversion factor, and indole
blocking factor.
SYNTHESIS OF '251I-LABELED f3-MSH FOR ANALYSES
OF MSH RECEPTORS
Freychet, Roth, and Neville reported the synthesis of'251I-labeled insulin in 1971
[31]. This achievement opened the way for studies on receptors for insulin and led to
the development oftechniques for iodination and isolation of many biologically active
peptide hormones. Varga et al. [10] first reported the synthesis of 251I-labeled f-MSH
and the use of this ligand to investigate MSH receptors in cultured melanoma cells.
Lambert, Lerner, and Varga later described an improved synthesis and purification of
'251-f-MSH which resulted in the isolation of a radioactive ligand that was mono-
iodinated at a single tyrosine residue and that retained full biological activity when
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compared to non-radioactive fl-MSH [1 1,32,33]. Their methods employed the use of
lodoGen (1, 3, 4, 6-tetrachloro-3, 6-diphenylglycoluril, Pierce Chemicals, Inc.) as a
catalyst during the iodination reaction, and isolation of the '25I-_-MSH by reversed
phase high-performance liquid chromatography. Recently, the number of studies on
receptors for MSH has increased markedly, as has a concommitant need fora supply of
'251-MSH. Improvements on the original techniques have now led to methodology
wherein millicurie amounts of '251-MSH can be isolated and stored for at least six
weeks [34]. The continued advancement of this and related technology [35] has been
of major importance to progress in the studies on the structure and function of
receptors for MSH.
CELL-CYCLE SPECIFIC EXPRESSION OF RECEPTORS FOR MSH
In 1974 it was reported that at least some of the responses to MSH (e.g., increased
cyclic AMP production and tyrosinase activity) occur in the G2 phase ofthe cell cycle
[36] and that the apparent reason for this cell cycle restriction is that receptors for
MSH are most active in the G2 phase [10]. However, in the earlier work, the
mechanism(s) for increased receptor activity were not studied; e.g., were the receptors
increased in number or in affinity? We recently examined these phenomena in detail.
We found that by three separate methods of obtaining populations of cells in the G2
phase oftheir cycle-centrifugal elutriation, or synchronization with either colchicine
or thymidine-there was increased binding of MSH by cells in the G2- and possibly
late S-phases of their cycle. However, cultures of cells passing through their cycle in
synchrony were quite different from non-synchronized (random) cultures. Both
synchronized and random cultures expressed receptors for MSH in the G2- and
possibly late S-phase oftheircycle, but synchronized cultures bound 15-20 times more
MSH per cell than random cultures. This increased binding of MSH by synchronized
cells was accompanied by an increase in tyrosinase activity, providing direct proofofa
relationship between cellular binding of MSH and cellular responsiveness to MSH.
Analyses by Scatchard and Hill methods indicated that receptors from synchronized
cells exhibited positive cooperativity, while receptors from random populations ofcells
exhibited no cooperativity [37].
Understanding the nature of these differences in receptor populations should be of
fundamental value in understanding the mechanism of action of the MSH-receptor
complex in regulating proliferation and pigmentation.
DOPA PHOSPHATES: A NEW CLASS OF COMPOUNDS WHICH
REGULATE PIGMENT BIOSYNTHESIS AND CELLULAR
RESPONSIVENESS TO MSH
One problem in many ofthe studies on the regulation ofpigmentation is that the key
metabolite, namely L-dopa, is relatively insoluble (maximum solubility is approxi-
mately 5 mM in aqueous solution at neutral pH), and isconverted readily to melanin in
the presence of02 above pH 7. Thus many studies with cultured pigment cells or with
melanomas in animals are difficult to carry out or to interpret when L-dopa is a
component of the experiment. With this problem in mind, procedures were designed
for attaching phosphate groups to the oxygens on the 3- and/or 4-positions of the
phenylalanine ring [38]. The rationale was that such compounds would be stable to
oxidation and far more soluble than dopa itself. It was reasoned that, if melanocytes
were able to take up these compounds, the cellular phosphatases might catalytically
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hydrolyze the phosphate groups and in the process produce free L-dopa. Results ofour
studies with these compounds are summarized as follows: Dopa phosphates are highly
soluble compounds which are stable over a wide range of pH values and are not
hydrolyzed by boiling in concentrated acid. Synthetic yields ofgreater than 90 percent
can be obtained using dopa as starting material. Exposure to alkaline phosphatase
results in hydrolysis of the phosphate moieties and production of dopa. Dopa
phosphates do not inhibit dopa oxidase (tyrosinase) activity. Dopa oxidase does not
catalyze the conversion of dopa phosphates into melanin unless the dopa phosphates
are first treated with phosphatase. Dopa phosphates, when compared to L-dopa, are
stable in the presence of02 and are not oxidized by serum proteins. In the presence of
cultured melanoma cells, dopa phosphates are readily converted into melanin, indicat-
ing that the cells are able to produce dopa from dopa phosphates. At high concentra-
tions, dopa phosphates are cytotoxic toward melanoma cells in culture. The cytotoxic-
ity is enhanced at least threefold by pretreatment of cells with melanotropin (MSH),
and prevented by phenylthiourea, an inhibitor of dopa oxidase activity. These results,
combined with studies on the uptake ofradioactive forms ofdopa phosphates (32P and
14C) indicate that phosphorylated isomers of dopa are efficiently taken up by
Cloudman melanoma cells and are readily converted by the cells into a melanin
precursor, presumably L-dopa [39].
The above findings with dopa phosphates were obtained when the compounds were
used at relatively high concentrations (10-3M). A surprising finding emerged during
investigations into possible effects of dopa phosphates on the activity of receptors for
MSH [40]. Using '251-MSH as a tracer, we found that preincubation of Cloudman
melanoma cells with very low concentrations of dopa phosphates (106-10-5M)
resulted in a three- to fourfold stimulation of MSH receptor activity. In addition, the
stimulation of receptor activity was followed by a marked increase in MSH-mediated
stimulation oftyrosinase activity and melanin deposition. Scatchard analyses indicated
that the stimulation ofreceptor activity occurred through an increase in the affinity of
the receptors for MSH rather than through an increase in the number of receptors.
Apparently, at low concentrations dopa phosphates act either directly or indirectly as
cofactors for the MSH receptors. It is important to notethat, at the low concentrations,
dopa phosphates did not increase tyrosinase activity or melanin content; rather they
increased the cellular responsiveness to MSH [40].
The effects of dopa phosphates on melanoma cells in culture were consistent with
findings in similar in vivo studies on SKH2 mice [41]. At high concentrations (0.1
percent) pigmentation was suppressed, while at low concentrations (0.01 percent)
pigmentation was enhanced. It is possible that the reduction in skin pigment with high
concentrations of dopa phosphates was due to the cytotoxic effects of melanin
intermediates described above, while the stimulation of pigmentation with low
concentrations ofdopa phosphates was due to a stimulation ofreceptors for MSH.
CONCLUSIONS
Hormonal regulation of cellular proliferation and the expression of differentiated
functions in a number of cell types is a topic of considerable attention. As with most
biological studies, the increased numberofobservations has underlined thediversity of
the topics and raised more questions than originally imagined. The studies on
Cloudman melanoma cells and their regulation by MSH presented here represent a
good example of this situation. Although we have made several observations on the
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regulation of proliferation and pigmentation, the findings have indicated that the
regulation of these functions is highly complex and still poorly understood. Nonethe-
less, the fact that these cells grow in culture and respond to MSH, the ability to
manipulate them genetically, the development ofradioactive MSH as a tracer, and the
development of new techniques such as production of monoclonal antibodies and the
ability to clone genes should all be of assistance in the future progress of work on this
system.
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